JW Pharmaceutical Corp
KRX:001060

Watchlist Manager
JW Pharmaceutical Corp Logo
JW Pharmaceutical Corp
KRX:001060
Watchlist
Price: 26 700 KRW -0.56% Market Closed
Market Cap: 636.5B KRW

Intrinsic Value

The intrinsic value of one JW Pharmaceutical Corp stock under the Base Case scenario is 49 663.1 KRW. Compared to the current market price of 26 700 KRW, JW Pharmaceutical Corp is Undervalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
49 663.1 KRW
Undervaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
JW Pharmaceutical Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about JW Pharmaceutical Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JW Pharmaceutical Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for JW Pharmaceutical Corp.

Explain Valuation
Compare JW Pharmaceutical Corp to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about JW Pharmaceutical Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
JW Pharmaceutical Corp

Current Assets 324.8B
Cash & Short-Term Investments 72.5B
Receivables 125.3B
Other Current Assets 127B
Non-Current Assets 265.3B
Long-Term Investments 35.8B
PP&E 162.4B
Intangibles 51.1B
Other Non-Current Assets 15.9B
Current Liabilities 230.5B
Accounts Payable 121.5B
Short-Term Debt 41.3B
Other Current Liabilities 67.6B
Non-Current Liabilities 36.3B
Long-Term Debt 19.8B
Other Non-Current Liabilities 16.5B
Efficiency

Free Cash Flow Analysis
JW Pharmaceutical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
JW Pharmaceutical Corp

Revenue
742.8B KRW
Cost of Revenue
-398.7B KRW
Gross Profit
344.2B KRW
Operating Expenses
-253.8B KRW
Operating Income
90.4B KRW
Other Expenses
-41.5B KRW
Net Income
48.8B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

JW Pharmaceutical Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Healthy Gross Margin
Positive 3Y Average ROE
56/100
Profitability
Score

JW Pharmaceutical Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

JW Pharmaceutical Corp's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
71/100
Solvency
Score

JW Pharmaceutical Corp's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
JW Pharmaceutical Corp

Wall Street analysts forecast JW Pharmaceutical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JW Pharmaceutical Corp is 34 680 KRW with a low forecast of 34 340 KRW and a high forecast of 35 700 KRW.

Lowest
Price Target
34 340 KRW
29% Upside
Average
Price Target
34 680 KRW
30% Upside
Highest
Price Target
35 700 KRW
34% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JW Pharmaceutical Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one JW Pharmaceutical Corp stock?

The intrinsic value of one JW Pharmaceutical Corp stock under the Base Case scenario is 49 663.1 KRW.

Is JW Pharmaceutical Corp stock undervalued or overvalued?

Compared to the current market price of 26 700 KRW, JW Pharmaceutical Corp is Undervalued by 46%.

Back to Top